Free Trial

Maravai LifeSciences (MRVI) Insider Trading & Ownership

Maravai LifeSciences logo
$5.70 -0.08 (-1.38%)
(As of 11/12/2024 ET)

Maravai LifeSciences (NASDAQ:MRVI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.63%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$987,000.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$97.52 M
Get MRVI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Maravai LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MRVI Insider Buying and Selling by Quarter

Maravai LifeSciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Carl HullInsiderBuy175,000$5.64$987,000.00  
5/28/2024Gtcr Investment Xi LlcDirectorSell9,940,974$9.81$97,520,954.94  
(Data available from 1/1/2013 forward)

MRVI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Maravai LifeSciences includes Carl Hull, and Gtcr Investment Xi Llc. Learn more on insiders at MRVI.

0.63% of Maravai LifeSciences stock is owned by insiders. Learn more on MRVI's insider holdings.

The following insider purchased MRVI shares in the last 24 months: Carl Hull ($987,000.00).

Insiders have purchased a total of 175,000 MRVI shares in the last 24 months for a total of $987,000.00 bought.

The following insider sold MRVI shares in the last 24 months: Gtcr Investment Xi Llc ($97,520,954.94).

Insiders have sold a total of 9,940,974 Maravai LifeSciences shares in the last 24 months for a total of $97,520,954.94 sold.

Maravai LifeSciences Key Executives

  • Mr. Carl W. Hull (Age 65)
    Co-Founder & Executive Chairman
    Compensation: $617.67k
    1 recent trades
  • Mr. William E. Martin III (Age 49)
    CEO & Director
    Compensation: $987.86k
  • Mr. Kevin M. Herde (Age 52)
    Executive VP & CFO
    Compensation: $548.62k
  • Dr. Peter Michael Leddy Ph.D. (Age 61)
    Executive VP & Chief Administrative Officer
    Compensation: $583.39k
  • Ms. Christine Dolan (Age 56)
    Executive VP & GM of Cygnus Technologies
    Compensation: $536.63k
  • Mr. Andrew Burch (Age 55)
    President of Nucleic Acid Production
    Compensation: $425.15k
  • Ms. Debra Hart
    Senior Director of Investor Relations
  • Mr. Kurt Oreshack (Age 43)
    Executive VP, General Counsel & Secretary
    Compensation: $701.4k
  • Ms. Rebecca Buzzeo
    Executive VP & Chief Commercial Officer
  • Dr. Kate E. Broderick Ph.D.
    Chief Innovation Officer


This page (NASDAQ:MRVI) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners